| | | | | |
NAUT Nautilus Biotechnolgy, Inc. Common Stock | $2,0650 | +3,25% | $254,15M | $2,49M | |
OTLK Outlook Therapeutics, Inc. Common Stock | $1,7100 | +0,00% | $254,08M | $36,01K | |
SIDU Sidus Space, Inc. Class A Common Stock | $2,6300 | +0,77% | $254,08M | $106,41K | |
GLO Clough Global Opportunities Fund | $5,9400 | +0,00% | $254,03M | $64,93K | |
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares | $4,2450 | +0,12% | $253,89M | $6,000 | |
FULC Fulcrum Therapeutics, Inc. Common Stock | $3,8100 | +0,26% | $253,20M | $42,00 | |
IKT Inhibikase Therapeutics, Inc. Common Stock | $1,8900 | -1,05% | $252,18M | $685,93K | |
FCT First Trust Senior Floating Rate Income Fund II | $9,7000 | +0,00% | $252,03M | $188,74K | |
ATGL Alpha Technology Group Limited Class A Ordinary Shares | $11,5000 | +0,26% | $251,62M | $3,000 | |
ACRE Ares Commercial Real Estate Corporation | $4,5800 | +1,55% | $250,21M | $2,000 | |
SCII SC II Acquisition Corp. Class A ordinary share | $10,0500 | +0,00% | $249,22M | $2,000 | |
USAU U.S. Gold Corp. Common Stock | $15,0500 | -0,13% | $248,67M | $209,00 | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | $5,2600 | +0,00% | $248,39M | $116,75K | |
EVGO EVgo Inc. Class A Common Stock | $1,7700 | +0,57% | $248,26M | $1,51K | |
QADR QDRO Acquisition Corp. Class A Ordinary Shares | $9,9000 | -0,25% | $248,12M | $9,000 | |
